52
Views
8
CrossRef citations to date
0
Altmetric
Case Series

Surgical management of fibrotic encapsulation of the fluocinolone acetonide implant in CAPN5-associated proliferative vitreoretinopathy

, , &
Pages 1093-1098 | Published online: 10 Jun 2013

References

  • MahajanVBSkeieJMBassukAGCalpain-5 mutations cause autoimmune uveitis, retinal neovascularization, and photoreceptor degenerationPLoS Genet2012810e100300123055945
  • BennettSRFolkJCKimuraAERussellSRStoneEMRaphtisEMAutosomal dominant neovascular inflammatory vitreoretinopathyOphthalmology1990979112511352234842
  • MahajanVBValloneJGLinJHT-cell infiltration in autosomal dominant neovascular inflammatory vitreoretinopathyMolecular Vision2010161034104020596252
  • TlucekPSFolkJCOrienJAStoneEMMahajanVBInhibition of neovascularization but not fibrosis with the fluocinolone acetonide implant in autosomal dominant neovascular inflammatory vitreoretinopathyArch Ophthalmol2012130111395140122777573
  • JaffeGJMcCallumRMBranchaudBSkalakCButunerZAshtonPLong-term follow-up results of a pilot trial of a fluocinolone acetonide implant to treat posterior uveitisOphthalmology200511271192119815921758
  • CallananDGJaffeGJMartinDFPearsonPAComstockTLTreatment of posterior uveitis with a fluocinolone acetonide implant: three-year clinical trial resultsArc Ophthalmol2008126911911201
  • BandelloFPolitoAPognuzDRMonacoPDimastrogiovanniAPaissiosJTriamcinolone as adjunctive treatment to laser panretinal photocoagulation for proliferative diabetic retinopathyArch Ophthalmol2006124564365016682585
  • ChanCKIpMSVanveldhuisenPCSCORE Study report #11: incidences of neovascular events in eyes with retinal vein occlusionOphthalmology201111871364137221440942
  • JonasJBHaylerJKSofkerAPanda-JonasSIntravitreal injection of crystalline cortisone as adjunctive treatment of proliferative diabetic retinopathyAm J Ophthalmol2001131446847111292410
  • MunirWMPulidoJSSharmaMCBuerkBMIntravitreal triamcinolone for treatment of complicated proliferative diabetic retinopathy and proliferative vitreoretinopathyCan J Ophthalmol200540559860416391623
  • ChenWChenHHouPFokAHuYLamDSMidterm results of low-dose intravitreal triamcinolone as adjunctive treatment for proliferative vitreoretinopathyRetina20113161137114221317835
  • AhmadiehHFeghhiMTabatabaeiHShoeibiNRamezaniAMohebbiMRTriamcinolone acetonide in silicone-filled eyes as adjunctive treatment for proliferative vitreoretinopathy: a randomized clinical trialOphthalmology2008115111938194318584876
  • TangLEatonJWInflammatory responses to biomaterialsAm J Clin Pathol199510344664717726145
  • TangLEatonJWNatural responses to unnatural materials: A molecular mechanism for foreign body reactionsMol Med19995635135810415159
  • MahajanVBGehrsKMGoldsteinDAFischerDHLopezJSFolkJCManagement of sympathetic ophthalmia with the fluocinolone acetonide implantOphthalmology2009116355255719147232
  • PearsonPAComstockTLIpMFluocinolone acetonide intravitreal implant for diabetic macular edema: a 3-year multicenter, randomized, controlled clinical trialOphthalmology201111881580158721813090
  • PatelCCMandavaNOliverSCBravermanRQuiroz-MercadoHOlsonJLTreatment of intractable posterior uveitis in pediatric patients with the fluocinolone acetonide intravitreal implant (Retisert)Retina201232353754221963487
  • TarantolaRMGraffJMSomaniRMahajanVBTemporal approach for small-gauge pars plana vitrectomy combined with anterior segment surgeryRetina20123281614162322511071
  • DehghanMHAhmadiehHSoheilianMEffect of oral prednisolone on visual outcomes and complications after scleral bucklingEur J Ophthalmol201020241942319924670
  • GalorAMargolisRKaiserPKLowderCYVitreous band formation and the sustained-release, intravitreal fluocinolone (Retisert) implantArch Ophthalmol2007125683683817562999
  • JainNStinnettSSJaffeGJProspective study of a fluocinolone acetonide implant for chronic macular edema from central retinal vein occlusion: thirty-six-month resultsOphthalmology2012119113213721924503
  • Multicenter Uveitis Steroid Treatment (MUST) Trial Research GroupKempenJHAltaweelMMHolbrookJTRandomized comparison of systemic anti-inflammatory therapy versus fluocinolone acetonide implant for intermediate, posterior, and panuveitis: the multicenter uveitis steroid treatment trialOphthalmology2011118101916192621840602
  • PavesioCZierhutMBairiKComstockTLUsnerDWEvaluation of an intravitreal fluocinolone acetonide implant versus standard systemic therapy in noninfectious posterior uveitisOphthalmology2010117356757520079922
  • AhmadZMHughesBAAbramsGWMahmoudTHCombined posterior chamber intraocular lens, vitrectomy, Retisert, and pars plana tube in noninfectious uveitisArch Ophthalmol2012130790891322776928
  • MoltenoACFucikMDempsterAGBevinTHOtago Glaucoma Surgery Outcome Study: factors controlling capsule fibrosis around Molteno implants with histopathological correlationOphthalmology2003110112198220614597530
  • PolikovVSTrescoPAReichertWMResponse of brain tissue to chronically implanted neural electrodesJ Neurosci Methods2005148111816198003
  • BohlARohmHWCeschiPDevelopment of a specially tailored local drug delivery system for the prevention of fibrosis after insertion of cochlear implants into the inner earJ Mater Sci Mater Med20122392151216222706626
  • ParratteSBoyerPPiriouPTotal knee replacement following intra-articular malunionOrthop Traumatol Surg Res201197Suppl 6S118S12321872547
  • ButlerKRJrBenghuzziHAImmunohistochemical detection of cytokine expression in tissue-implant response associated with TCP bioceramic implants loaded with steroid hormonesBiomed Sci Instrum20033954154612724949
  • HickeyTKreutzerDBurgessDJMoussyFIn vivo evaluation of a dexamethasone/PLGA microsphere system designed to suppress the inflammatory tissue response to implantable medical devicesJ Biomed Mater Res200261218018712007197
  • PatilSDPapadimitrakopoulosFBurgessDJDexamethasone-loaded poly(lactic-co-glycolic) acid microspheres/poly(vinyl alcohol) hydrogel composite coatings for inflammation controlDiabetes Technol Ther20046688789715684644